Axsome Therapeutics’ (AXSM) Buy Rating Reaffirmed at HC Wainwright
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a research report issued on Thursday,Benzinga reports. They presently have a $180.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 71.31% from the company’s current price. Several […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a research report issued on Thursday,Benzinga reports. They presently have a $180.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 71.31% from the company’s current price. Several […]
